1. Taieb A, Picardo M; VETF Members. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007;20:27-35.
2. Lee H, Lee MH, Lee DY, Kang HY, Kim KH, Choi GS, Shin J, Lee HJ, Kim DH, Kim TH, Lee AY, Lee SC, Lee S, Kim KW, Hann SK, Park CJ, Oh SH. Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J 2015;56:719-725.
3. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol 2005;152:1165-1172.
4. Kim DY, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ. Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles. J Dermatol 2009;36:317-322.
5. Nordlund JJ, Lerner AB. Vitiligo. It is important. Arch Dermatol 1982;118:5-8.
6. Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988;118:223-228.
7. Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri L, Spritz R, Gauthier Y, Hann SK, Picardo M, Taieb A; Vitiligo Global Issue Consensus Conference Panelists. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2012;25:E1-E13.
8. Taieb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med 2009;360:160-169.
9. Saleem MD, Oussedik E, Schoch JJ, Berger AC, Picardo M. Acquired disorders with depigmentation: a systematic approach to vitiliginoid conditions. J Am Acad Dermatol 2019;80:1215-1231.e6.
11. Hann SK, Park YK, Chun WH. Clinical features of vitiligo. Clin Dermatol 1997;15:891-897.
12. Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol 1997;36:353-355.
13. Goh BK, Pandya AG. Presentations, signs of activity, and differential diagnosis of vitiligo. Dermatol Clin 2017;35:135-144.
14. Ezzedine K, Le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res 2014;27:134-139.
15. Passeron T, Ortonne JP. Generalized vitiligo. In: Picardo M, Taieb A, editor. Vitiligo. Berlin: Springer-Verlag; 2010. p. 35-39.
16. Handa S, Kaur I. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999;26:653-657.
17. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-666.
18. Dave S, Thappa DM, Dsouza M. Clinical predictors of outcome in vitiligo. Indian J Dermatol Venereol Leprol 2002;68:323-325.
19. Mulekar SV, Al Issa A, Asaad M, Ghwish B, Al Eisa A. Mixed vitiligo. J Cutan Med Surg 2006;10:104-107.
21. Ezzedine K, Gauthier Y, Leaute-Labreze C, Marquez S, Bouchtnei S, Jouary T, Taieb A. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol 2011;65:965-971.
22. Ezzedine K, Diallo A, Leaute-Labreze C, Seneschal J, Prey S, Ballanger F, Alghamdi K, Cario-Andre M, Jouary T, Gauthier Y, Taieb A. Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br J Dermatol 2012;166:539-544.
23. Neri I, Russo T, Piccolo V, Patrizi A. Mixed vitiligo in childhood: a study on 13 Italian patients. J Eur Acad Dermatol Venereol 2013;27:e140-e141.
24. Happle R. Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol 2007;57:690-699.
25. Lee SJ, Cho SB, Hann SK. Classification of vitiligo. In: Gupta S, editor. Surgical management of vitiligo. Oxford: John Wiley & Sons; 2008. p. 20-30.
26. el-Mofty AM, el-Mofty M. Vitiligo. A symptom complex. Int J Dermatol 1980;19:237-244.
27. Song MS, Hann SK, Ahn PS, Im S, Park YK. Clinical study of vitiligo: comparative study of type A and type B vitiligo. Ann Dermatol 1994;6:22-30.
28. Hann SK, Lee HJ. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996;35:671-674.
29. Barona MI, Arrunategui A, Falabella R, Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 1995;33:621-625.
31. Lee DY, Kim CR, Park JH, Lee JH. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment. Int J Dermatol 2011;50:925-927.
32. Lee DY, Park JH, Lee JH, Yang JM, Lee ES. Poor response of phototherapy in segmental vitiligo with leukotrichia: role of digital microscopy. Int J Dermatol 2012;51:873-875.
33. Park JH, Park SW, Lee DY, Lee JH, Yang JM. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration. Photodermatol Photoimmunol Photomed 2013;29:103-105.
34. Do JE, Shin JY, Kim DY, Hann SK, Oh SH. The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed 2011;27:147-151.
35. Nelhaus G. Acquired unilateral vitiligo and poliosis of the head and subacute encephalitis with partial recovery. Neurology 1970;20:965-974.
36. Jang HS, Kim MR, Hann SK, Oh SH. Segmental vitiligo and facial palsy associated with a concurrent ipsilateral acoustic schwannoma. J Dermatol 2013;40:291-292.
38. van Geel N, Mollet I, Brochez L, Dutre M, De Schepper S, Verhaeghe E, Lambert J, Speeckaert R. New insights in segmental vitiligo: case report and review of theories. Br J Dermatol 2012;166:240-246.
39. Shin S, Shin JY, Lee H, Oh SH. Spreading of pre-existing segmental vitiligo after immunotherapy with house dust mite in a patient with atopic dermatitis. Clin Exp Dermatol 2015;40:920-921.
40. Shin J, Kang HY, Kim KH, Park CJ, Oh SH, Lee SC, Lee S, Choi GS, Hann SK. Involvement of T cells in early evolving segmental vitiligo. Clin Exp Dermatol 2016;41:671-674.
41. Ezzedine K. Vitiligo. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editor. Fitzpatrickʼs dermatology. 9th ed. New York: MaGraw-Hill; 2019. p. 1330-1350.
42. Taieb A. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 2000;13 Suppl 8:41-47.
44. Kim DY, Oh SH, Hann SK. Classification of segmental vitiligo on the face: clues for prognosis. Br J Dermatol 2011;164:1004-1009.
45. Hann SK, Gauthier Y, Benzekri L. Segmental vitiligo. In: Picardo M, Taieb A, editor. Vitiligo. Berlin: Springer-Verlag; 2010. p. 41-49.
46. van Geel N, Bosma S, Boone B, Speeckaert R. Classification of segmental vitiligo on the trunk. Br J Dermatol 2014;170:322-327.
47. Lommerts JE, Schilder Y, de Rie MA, Wolkerstorfer A, Bekkenk MW. Focal vitiligo: long-term follow-up of 52 cases. J Eur Acad Dermatol Venereol 2016;30:1550-1554.
48. Zaima H, Koga M. Clinical course of 44 cases of localized type vitiligo. J Dermatol 2002;29:15-19.
49. van Geel N, Speeckaert R, De Wolf J, Bracke S, Chevolet I, Brochez L, Lambert J. Clinical significance of Koebner phenomenon in vitiligo. Br J Dermatol 2012;167:1017-1024.
50. Fargnoli MC, Bolognia JL. Pentachrome vitiligo. J Am Acad Dermatol 1995;33:853-856.
51. Hann SK, Kim YS, Yoo JH, Chun YS. Clinical and histopathologic characteristics of trichrome vitiligo. J Am Acad Dermatol 2000;42:589-596.
52. Sharquie KE, Mehenna SH, Naji AA, Al-Azzawi H. Inflammatory changes in vitiligo: stage I and II depigmentation. Am J Dermatopathol 2004;26:108-112.
53. Attili VR, Attili SK. Lichenoid inflammation in vitiligo: a clinical and histopathologic review of 210 cases. Int J Dermatol 2008;47:663-669.
54. Lee D, Lazova R, Bolognia JL. A figurate papulosquamous variant of inflammatory vitiligo. Dermatology 2000;200:270-274.
55. Shin J, Lee JS, Kim MR, Kim DY, Hann SK, Oh SH. New suggestive clue to the mechanism of vitiligo: inflammatory vitiligo showing prominent leukocytoclasis at the erythematous rim. J Dermatol 2013;40:488-490.
56. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996;148:1219-1228.
57. Sosa JJ, Currimbhoy SD, Ukoha U, Sirignano S, OʼLeary R, Vandergriff T, Hynan LS, Pandya AG. Confetti-like depigmentation: A potential sign of rapidly progressing vitiligo. J Am Acad Dermatol 2015;73:272-275.
58. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, Anstey AV, Ingham J, Young K; Therapy Guidelines and Audit Subcommittee; British Association of Dermatologists; Clinical Standards Department; Royal College of Physicians of London; Cochrane Skin Group; Vitiligo Society. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008;159:1051-1076.
59. Klatte JL, van der Beek N, Kemperman PM. 100 Years of Woodʼs lamp revised. J Eur Acad Dermatol Venereol 2015;29:842-847.
60. Thatte SS, Khopkar US. The utility of dermoscopy in the diagnosis of evolving lesions of vitiligo. Indian J Dermatol Venereol Leprol 2014;80:505-508.
61. Kumar Jha A, Sonthalia S, Lallas A, Chaudhary RKP. Dermoscopy in vitiligo: diagnosis and beyond. Int J Dermatol 2018;57:50-54.
62. Tey HL. Approach to hypopigmentation disorders in adults. Clin Exp Dermatol 2010;35:829-834.
63. Kim SK, Kang HY, Lee ES, Kim YC. Clinical and histopathologic characteristics of nevus depigmentosus. J Am Acad Dermatol 2006;55:423-428.